Immunohistochemical detection of insulin-like growth factor type I receptor and uterine volume changes in gonadotropin-releasing hormone analog - Treated uterine leiomyomas

American Journal of Obstetrics and Gynecology

Volumn 188, Issue 3, 2003, Pages 702-706

  Di Lieto, Andrea ^a,b   Iannotti, Francesca ^a   De Falco, Marianna ^a   Staibano, Stefania ^a   Pollio, Fabrizio ^a   Ciociola, Francesca ^a   De Rosa, Gaetano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

Gonadotropin releasing hormone analog treatment; Insulin like growth factor type I receptor; Uterine leiomyomas; Uterine volume changes

Indexed keywords

GONADORELIN DERIVATIVE; LEUPRORELIN; SOMATOMEDIN C RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ITALY; MENORRHAGIA; ORGAN SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BIOPSY; UTERUS MYOMA;

EID: 0037339724     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.180     Document Type: Article

References (24)

1. Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev 2000;2:CD000547.
2. Gonzales-Barcena D, Alvarez RB, Ochoa EP, Cornejo IC, Comaru-Schally AM, Schally AV, et al. Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix. Hum Reprod 1997;12:2028-35.
3. Filicori M, Hall DA, Loughlin JS, Rivier J, Vale W, Crowley WF. A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone - releasing hormone analogue. Am J Obstet Gynecol 1983;147:726-7.
4. Friedman AJ, Lobel SM, Rein MS. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis. Am J Obstet Gynecol 1990;163:1114-9.
5. Yeh J, Rein M, Nowak R. Presence of messenger ribonucleic acid for epidermal growth factor (EGF) and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata. Fertil Steril 1991;56:997-1000.
6. Harrison-Woolrych ML, Charnock-Jones DS, Smith SK. Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcription polymerase chain reaction. J Clin Endocrinol Metab 1994;78:1179-84.
7. Rein MS, Friedman AJ, Pandian MR, Heffner LJ. The secretion of insulin-like growth factors I and II explant cultures of fibroids and myometrium from women treated with gonadotropin-releasing hormone agonist. Obstet Gynecol 1990;76:388-94.
8. Strawn EY, Novy MJ, Burry KA, Bethea CL. Insulin-like growth factor I promotes leiomyoma cell growth in vitro. Am J Obstet Gynecol 1995;172:1837-44.
9. Giudice LC, Irwin JC, Duspin BA, Pannier EM, Jin IH, Vu TH, et al. Insulin-like growth factor (IGF), IGF binding protein (IGFBP) and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata. Hum Reprod 1993;8:1796-806.
10. Burroughs KD, Howe SR, Okubo Y, Fuchs-Young R, LeRoith D, Walker CL. Dysregulation of insulin-like growth factor-I signaling in uterine leiomyoma. J Endocrinol 2002;172:83-93.
11. Barbarisi A, Petillo O, Di Lieto A, Melone MAB, Margarucci S, Cannas M, et al. 17-β estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway. J Cell Physiol 2001;186:414-24.
12. Andersen J. Growth factors and cytokines in uterine leiomyomas. Semin Reprod Endocrinol 1996;14:269-82.
13. Dixon D, He H, Haseman JK. Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium. Environ Health Perspect 2000;108(5 Suppl):795-802.
14. Lumsden MA, West CP, Baerd DT. Goserelin therapy before surgery for uterine fibroids. Lancet 1987;1:36-7.
15. Englund K, Lindblom B, Carlström K, Gustavsson I, Sjöblom P, Blanck A. Gene expression and tissue concentrations of IGF-1 in human myometrium and fibroids under different hormonal conditions. Mol Hum Reprod 2000;6:915-20.
16. Shimomura Y, Matsuo H, Samoto T, Maruo T. Up regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J Clin Endocrinol Metab 1998;83:2192-8.
17. Vollenhoven BJ, Herrington AC, Healy DL. Messenger ribonucleic acid expression of the insulin like growth factors and their bindings proteins in uterine fibroids and myometrium. J Clin Endocrinol Metab 1993;76:1106-10.
18. Van Der Ven LTM, Gloudemans T, Roholl RJM, Van Bull-Offers SC, Bladergroen BA, Welters MJP, et al. Growth advantage of human leiomyoma cells compared to normal smooth-muscle cells due to enhanced sensitivity toward insulin-like growth factor I. Int J Cancer 1994;59:427-34.
19. Van Der Ven LTM, Roholl PJM, Gloudemans T, Van Bull-Offers SC, Welters MJP, Bladergroen BA, et al. Expression of insuline-like growth factors (IGFs), their receptors and IGF binding protein-3 in normal, benign and malignant smooth muscle tissues. Br J Cancer 1997:1631-40.
20. Chandrasekhar Y, Heiner J, Osuampke C, Nagamani M. Insulin-like growth factor I and II binding in human myometrium and leiomyomas. Am J Obstet Gynecol 1992;166:64-9.
21. Tommola P, Pekonen F, Rutanen EM. Binding of epidermal growth factor and insuline-like growth factor I in human myometrium and leiomyomata. Obstet Gynecol 1989;74:658-62.
22. Chegini N, Rong H, Dou Q, Kipersztok S, Williams RS. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro. J Clin Endocrinol Metab 1996;81:3215-21.
23. Emons G, Ortmann O, Becker M, Irmer G, Springer B, Laun R, et al. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines. Cancer Res 1993;53:5439-46.
24. Emons G, Schröder B, Ortmann O, Westphalen S, Schulz KD, Schally AV. High affinity binding and direct antiproliferative effects of LHRH analogues in human endometrial cancer cell lines. J Clin Endocrinol Metab 1993;77:1458-64.